• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

光动力疗法相关的宿主反应及其在治疗结果中的作用。

PDT-associated host response and its role in the therapy outcome.

作者信息

Korbelik Mladen

机构信息

British Columbia Cancer Agency, Vancouver, British Columbia, Canada V5Z 1L3.

出版信息

Lasers Surg Med. 2006 Jun;38(5):500-8. doi: 10.1002/lsm.20337.

DOI:10.1002/lsm.20337
PMID:16634073
Abstract

BACKGROUND AND OBJECTIVES

The outcome of the treatment of solid tumors by photodynamic therapy (PDT) is critically dependent on the contribution from the host. This host response is provoked by the rapidly induced massive tumor tissue injury delivered by PDT that is experienced as a local trauma threatening the integrity and homeostasis at the affected site.

STUDY DESIGN/MATERIALS AND METHODS: Mouse tumor models were extensively employed in pre-clinical studies investigating various aspects of host-tumor interaction following PDT, but important input was also derived from clinical data.

RESULTS

The recognition of this PDT-inflicted insult by innate immune sensors detecting danger signals from the distressed/altered tumor tissue, triggers host-protecting responses dominantly manifested as acute inflammation that are elicited and orchestrated by the innate immune system. To secure the affected PDT-targeted site, the inflammatory reaction attacks tumor vasculature and then neutralizes the focal source of danger signals by eliminating the injured tumor cells.

CONCLUSION

The provoked highly intensified phagocytosis of dead tumor cells occurring in the context of a vigorous innate immune reaction emerges as a key factor responsible for the development of tumor antigen-specific adaptive immune response that contributes to the eradication of PDT-treated cancers.

摘要

背景与目的

光动力疗法(PDT)治疗实体瘤的效果严重依赖于宿主的作用。这种宿主反应是由PDT迅速引发的大量肿瘤组织损伤所激发的,这种损伤被视为一种局部创伤,威胁着受影响部位的完整性和内环境稳定。

研究设计/材料与方法:小鼠肿瘤模型被广泛应用于临床前研究,以探究PDT后宿主与肿瘤相互作用的各个方面,但重要的信息也来自临床数据。

结果

先天免疫传感器识别来自受损/改变的肿瘤组织的危险信号,从而认识到这种由PDT造成的损伤,触发主要表现为急性炎症的宿主保护反应,这种反应由先天免疫系统引发并协调。为了保护受影响的PDT靶向部位,炎症反应攻击肿瘤血管,然后通过清除受损的肿瘤细胞来中和危险信号的局部来源。

结论

在强烈的先天免疫反应背景下发生的对死亡肿瘤细胞的强烈吞噬作用,成为导致肿瘤抗原特异性适应性免疫反应发展的关键因素,这有助于根除接受PDT治疗的癌症。

相似文献

1
PDT-associated host response and its role in the therapy outcome.光动力疗法相关的宿主反应及其在治疗结果中的作用。
Lasers Surg Med. 2006 Jun;38(5):500-8. doi: 10.1002/lsm.20337.
2
Acute phase response-associated systemic neutrophil mobilization in mice bearing tumors treated by photodynamic therapy.光动力疗法治疗的荷瘤小鼠中与急性期反应相关的全身中性粒细胞动员
Int Immunopharmacol. 2006 Aug;6(8):1259-66. doi: 10.1016/j.intimp.2006.03.008. Epub 2006 Apr 19.
3
Adjuvant treatment for complement activation increases the effectiveness of photodynamic therapy of solid tumors.用于补体激活的辅助治疗可提高实体瘤光动力疗法的疗效。
Photochem Photobiol Sci. 2004 Aug;3(8):812-6. doi: 10.1039/b315663J. Epub 2004 Apr 2.
4
Dying cells program their expedient disposal: serum amyloid P component upregulation in vivo and in vitro induced by photodynamic therapy of cancer.垂死细胞安排自身的快速清除:癌症光动力疗法在体内和体外诱导血清淀粉样蛋白P成分上调。
Photochem Photobiol Sci. 2007 Dec;6(12):1284-9. doi: 10.1039/b709439f. Epub 2007 Sep 18.
5
Role of complement anaphylatoxin C3a in photodynamic therapy-elicited engagement of host neutrophils and other immune cells.补体过敏毒素C3a在光动力疗法引发的宿主中性粒细胞和其他免疫细胞参与过程中的作用。
Photochem Photobiol. 2006 Mar-Apr;82(2):558-62. doi: 10.1562/2005-09-09-RA-681.
6
Photodynamic therapy and anti-tumor immunity.光动力疗法与抗肿瘤免疫
Lasers Surg Med. 2006 Jun;38(5):509-15. doi: 10.1002/lsm.20362.
7
Antitumor immunity promoted by vascular occluding therapy: lessons from vascular-targeted photodynamic therapy (VTP).血管阻断疗法促进的抗肿瘤免疫:血管靶向光动力疗法(VTP)的启示。
Photochem Photobiol Sci. 2011 May;10(5):681-8. doi: 10.1039/c0pp00315h. Epub 2011 Jan 24.
8
Photodynamic therapy: combined modality approaches targeting the tumor microenvironment.光动力疗法:针对肿瘤微环境的联合治疗方法。
Lasers Surg Med. 2006 Jun;38(5):516-21. doi: 10.1002/lsm.20339.
9
Expression of complement and pentraxin proteins in acute phase response elicited by tumor photodynamic therapy: the engagement of adrenal hormones.补体和五聚素蛋白在肿瘤光动力疗法诱导的急性期反应中的表达:肾上腺激素的参与。
Int Immunopharmacol. 2010 Dec;10(12):1595-601. doi: 10.1016/j.intimp.2010.09.015. Epub 2010 Oct 8.
10
Fluence rate as a modulator of PDT mechanisms.光通量率作为光动力疗法机制的调节剂。
Lasers Surg Med. 2006 Jun;38(5):489-93. doi: 10.1002/lsm.20327.

引用本文的文献

1
Targeting ocular malignancies using a novel light-activated virus-like drug conjugate.使用新型光激活病毒样药物偶联物靶向眼部恶性肿瘤。
Adv Ophthalmol Pract Res. 2024 Dec 3;5(1):49-57. doi: 10.1016/j.aopr.2024.12.001. eCollection 2025 Feb-Mar.
2
Treatment of Conjunctival Melanoma Cell Lines With a Light-Activated Virus-Like Drug Conjugate Induces Immunogenic Cell Death.用光激活的病毒样药物偶联物治疗结膜黑色素瘤细胞系可诱导免疫原性细胞死亡。
Invest Ophthalmol Vis Sci. 2024 Nov 4;65(13):3. doi: 10.1167/iovs.65.13.3.
3
Enhancing cancer immunotherapy with photodynamic therapy and nanoparticle: making tumor microenvironment hotter to make immunotherapeutic work better.
用光动力疗法和纳米颗粒增强癌症免疫疗法:使肿瘤微环境更“热”以让免疫疗法效果更佳。
Front Immunol. 2024 Apr 5;15:1375767. doi: 10.3389/fimmu.2024.1375767. eCollection 2024.
4
PDT-Induced Activation Enhanced by Hormone Response to Treatment.激素对治疗的反应增强了光动力疗法诱导的激活。
Int J Mol Sci. 2023 Sep 10;24(18):13917. doi: 10.3390/ijms241813917.
5
TGF-β1 mediates tumor immunosuppression aggravating at the late stage post-high-light-dose photodynamic therapy.TGF-β1 介导肿瘤免疫抑制作用加剧,发生在高剂量光动力治疗后的晚期。
Cancer Immunol Immunother. 2023 Sep;72(9):3079-3095. doi: 10.1007/s00262-023-03479-3. Epub 2023 Jun 23.
6
Targeting Glioblastoma-Associated Macrophages for Photodynamic Therapy Using AGuIX-Design Nanoparticles.使用AGuIX设计的纳米颗粒靶向胶质母细胞瘤相关巨噬细胞进行光动力治疗
Pharmaceutics. 2023 Mar 20;15(3):997. doi: 10.3390/pharmaceutics15030997.
7
Current Challenges and Opportunities of Photodynamic Therapy against Cancer.光动力疗法治疗癌症的当前挑战与机遇
Pharmaceutics. 2023 Jan 18;15(2):330. doi: 10.3390/pharmaceutics15020330.
8
The "Light Knife" for Gastric Cancer: Photodynamic Therapy.用于胃癌的“光刀”:光动力疗法
Pharmaceutics. 2022 Dec 28;15(1):101. doi: 10.3390/pharmaceutics15010101.
9
Insight into the Prospects for Tumor Therapy Based on Photodynamic Immunotherapy.基于光动力免疫疗法的肿瘤治疗前景洞察。
Pharmaceuticals (Basel). 2022 Nov 4;15(11):1359. doi: 10.3390/ph15111359.
10
An Analysis of the Effects of In Vitro Photodynamic Therapy on Prostate Cancer Tissue by Histopathological Examination and Magnetic Resonance Imaging.经组织病理学检查和磁共振成像分析光动力学疗法对前列腺癌组织的影响。
Int J Mol Sci. 2022 Sep 26;23(19):11354. doi: 10.3390/ijms231911354.